Leveraging diverse cell-death patterns to predict the clinical outcome of immune checkpoint therapy in lung adenocarcinoma: Based on muti-omics analysis and vitro assay
Article in Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (January 2024)